Semaglutide’s New Indication Highlights Growing Role of GLP-1 Receptor Agonists
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
The Agency for Healthcare Research and Quality (AHRQ) Making Healthcare Safer (MHS) reports consolidate information for healthcare providers, health system administrators, researchers, and government agencies…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
It is worth examining the efforts to discover SARS-CoV-2’s origins. But regardless of the origins of the virus, the global community can take steps to…
March 2024 R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S. Prior to the COVID-19 pandemic, 95 percent of all emergency department (ED) visits…
This report evaluates disparities in health and health care across racial and ethnic groups, both within states and between U.S. states.
The purpose of this systematic review was to document and summarize reported barriers and facilitators to the receipt of selected clinical preventive services among people…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Use of digital healthcare technologies – for clinicians and patients – is growing. To ensure these solutions benefit all patient groups, creators and users must be…
This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their…